Connect with us

News

GLP-1 diabetes study: patients without gains often stay on drug

Published

on

The less effective group averaged a CCI of 2.1 and had at least one emergency room visit or hospital admission before starting. HbA1c in this group rose 0.1 percentage point, patients gained 2.7 percent of their body weight on average, and 83 percent still stayed on therapy for nine months or longer. For a self-insured employer paying per prescription, that is the pattern with the clearest cost implications.

How the obesity results compare

Among patients with obesity but no Type 2 diabetes, the more effective group lost 9.4 percent of body weight on average, and 84.5 percent lost at least 5 percent. Eighty percent stayed on therapy at nine months. These patients were more likely to be 44 or older, to weigh 175 to 299 pounds, to have no sleep disorder and to have filled fewer than three prescriptions for obesity-related conditions, such as hypertension, in the baseline period.

The less effective group still lost 5.3 percent on average, with 64.4 percent reaching the 5 percent mark and 76 percent staying on therapy for nine months. These patients tended to weigh less than 175 pounds or 300 pounds and above, and to be younger, for example under 40.

What can HR leaders do with the findings?

The study was observational, and HTA noted that it did not evaluate workforce outcomes such as productivity, absenteeism, disability or retention. Most results reflect about one year of follow-up, so long-term return on investment remains uncertain. Merative, the analytics firm whose claims data the study drew on, internally validated the predictive models.

“If we can better understand who is likely to see a meaningful health benefit, employers can focus on getting the right treatment to the right people rather than treating every prescription the same,” said Rob Andrews, chief executive of HTA.

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending